SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Bafna Pharmaceuticals board to consider share allotment

13 Sep 2012 Evaluate
Bafna Pharmaceuticals has informed that a meeting of the board of directors of the company will be held on September 15, 2012, to consider allotment of shares pursuant to conversion of warrants into shares, warrants allotted on March 17, 2011.

The above information is a part of company's filings submitted to BSE.

Bafna Pharmaceutical Share Price

221.00 -4.05 (-1.80%)
03-Jul-2026 12:16 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1911.55
Dr. Reddys Labs. 1375.20
Cipla 1461.25
Zydus Lifesciences 1127.60
Lupin 2468.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: